279 related articles for article (PubMed ID: 2483918)
1. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
Brown F
Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
[No Abstract] [Full Text] [Related]
2. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
Vol'pina OM; Surovoi AYu ; Ivanov VT
Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
[TBL] [Abstract][Full Text] [Related]
3. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
4. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
[TBL] [Abstract][Full Text] [Related]
5. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.
Doel TR; Gale C; Brooke G; DiMarchi R
J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649
[TBL] [Abstract][Full Text] [Related]
6. The potential of retro-inverso peptides as synthetic vaccines.
Van Regenmortel MH; Guichard G; Benkirane N; Briand JP; Muller S; Brown F
Dev Biol Stand; 1998; 92():139-43. PubMed ID: 9554267
[TBL] [Abstract][Full Text] [Related]
7. Mimicking foot-and-mouth disease virus antigens with synthetic peptides.
Rowlands DJ
Ann Sclavo Collana Monogr; 1984; 1(2):147-61. PubMed ID: 6100728
[No Abstract] [Full Text] [Related]
8. [Viral vaccines produced by gene technology and synthesis].
Hess RG
Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
[TBL] [Abstract][Full Text] [Related]
9. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
10. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
[TBL] [Abstract][Full Text] [Related]
11. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
[TBL] [Abstract][Full Text] [Related]
12. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
Parry NR; Ouldridge EJ; Barnett PV; Clarke BE; Francis MJ; Fox JD; Rowlands DJ; Brown F
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2919-30. PubMed ID: 2479714
[TBL] [Abstract][Full Text] [Related]
13. Peptide vaccine--a new approach to a safer foot-and-mouth disease virus vaccine.
Pfaff E; Thiel HJ; Böhm HO; Leban J
Arzneimittelforschung; 1987 Jan; 37(1):82-6. PubMed ID: 3032213
[TBL] [Abstract][Full Text] [Related]
14. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
[TBL] [Abstract][Full Text] [Related]
15. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
[TBL] [Abstract][Full Text] [Related]
16. New approaches to vaccination against foot-and-mouth disease.
Brown F
Vaccine; 1992; 10(14):1022-6. PubMed ID: 1335197
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptides as potential vaccines against foot-and-mouth disease.
Brown F
Endeavour; 1990; 14(2):87-94. PubMed ID: 1697533
[TBL] [Abstract][Full Text] [Related]
18. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi RD; Little SP; Gale C
Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of mice with plasmids expressing processed capsid protein of foot-and-mouth disease virus--importance of dominant and subdominant epitopes for antigenicity and protection.
Frimann TH; Barfoed AM; Aasted B; Kamstrup S
Vaccine; 2007 Aug; 25(33):6191-200. PubMed ID: 17640782
[TBL] [Abstract][Full Text] [Related]
20. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]